| Literature DB >> 35089602 |
Katie Ekberg1, Stuart Ekberg2,3, Lara Weinglass1, Anthony Herbert4,5,6, Johanna Rendle-Short7, Myra Bluebond-Langner8,9, Patsy Yates3,10, Natalie Bradford6, Susan Danby1,11.
Abstract
Children's agency in their own lives is increasingly recognised as important, including within paediatric health care. The issue of acknowledging child agency is complex in the context of paediatric palliative care, where children have serious and complex conditions that often impact their ability to verbally communicate with others. This study explores how clinicians and parents/guardians direct talk towards a child patient when they are present in a consultation. Conversation analysis methods were used to examine 74 video-recorded paediatric palliative care consultations. Detailed turn-by-turn examination of the recorded consultations identified the recurrent use of a practice described by linguists as a 'tag question', which follows some statement (e.g. 'he loves that, don't ya'). Both clinicians and parents/guardians often directed these tag questions towards the child patient. Analysis demonstrated how these tag questions: (1) validated the child's epistemic authority over what was being said and (2) made a child's response a possible, but not necessary, next action. The findings are discussed in relation to the sociology of child agency and how this agency is acknowledged and displayed within and through social interaction. This research provides direct evidence of children's competence as informants about their own symptoms.Entities:
Keywords: child agency; conversation analysis; paediatric palliative care; tag questions
Mesh:
Year: 2022 PMID: 35089602 PMCID: PMC9304193 DOI: 10.1111/1467-9566.13437
Source DB: PubMed Journal: Sociol Health Illn ISSN: 0141-9889
Child patient demographics
| Child | Sex | Age | Category | Diagnosis |
|---|---|---|---|---|
| F01 | M | 0.5 | Neurology | Cerebral palsy |
| F02 | M | 17 | Neurology | Duchenne muscular dystrophy |
| F03 | M | 17 | Neurology | Duchenne muscular dystrophy |
| F04 | M | 7 | Neurology | Schizencephaly |
| F05 | M | 1 | Oncology | T cell lymphoblastic lymphoma |
| F06 | F | 9 | Neurology | Cerebral palsy |
| F07 | M | 17 | Neurology | Cerebral palsy |
| F08 | M | 10 | Metabolic | Leukodystrophy |
| F09 | F | 6 | Neurology | Cerebral palsy |
| F10 | M | 5 | Neurology | Pontocerebellar hypoplasia |
| F11 | F | 14 | Neurology | Cerebral palsy |
| F12 | M | 7 | Metabolic | Mucopolysaccharidosis Type 3 (MPS III) |
| F13 | M | 15 | Metabolic | Mucopolysaccharidosis Type 3 (MPS III) |
| F14 | F | 9 | Neurology | Cerebral palsy |
| F15 | M | 3 | Neurology | Epileptic encephalopathy |
| F17 | M | 3 | Genetic | Phelan‐McDerind syndrome (22q13 microdeletion) |
| F18 | M | 3 | Neurology | Epileptic encephalopathy |
| F19 | F | 13 | Neurology | Cerebral palsy |
| F20 | F | 14 | Genetic | CDKL5 deficiency disorder |
| F21 | M | 7 | Metabolic | Lysosomal storage disorder |
| F22 | M | 5 | Neurology | Epileptic encephalopathy |
| F23 | M | 9 | Genetic | Lymphangiomatosis |
| F24 | F | 4 | Neurology | Pontocerebellar hypoplasia |
| F25 | M | 4 | Neurology | Genetic neurodevelopmental disorder |
| F26 | F | 3 | Neurology | Cerebral palsy |
| F27 | M | 5 | Cardiac | Congenital heart disease |
| F28 | M | 15 | Multi‐system | Gastrointestinal dysmotility, autism, epilepsy |
| F29 | M | 8 | Endocrine | Adrenal insufficiency |
| F30 | F | 12 | Neurology | Cerebral palsy |
| F31 | M | 11 | Neurology | Duchenne muscular dystrophy |
| F32 | F | 15 | Neurology | Cerebral palsy |
| F33 | F | 16 | Neurology | Undiagnosed neurodevelopmental disorder |
| F34 | M | 18 | Neurology | Epileptic encephalopathy |
| F35 | F | 12 | Genetic | CDKL5 deficiency disorder |
| F36 | M | 3 | Metabolic | Leukodystrophy |
| F37 | M | 16 | Neurology | Seizure disorder |
| F38 | F | 17 | Neurology | Cerebral palsy |
| F39 | M | 2 | Neurology | Merosin‐deficient muscular dystrophy |
| F40 | F | 8 | Neurology | Batten's disease |
| F41 | F | 10 | Neurology | Lissencephaly |
| F42 | F | 4 | Oncology | Diffuse intrinsic pontine glioma |
| F43 | M | 0.25 | Neurology | Myotubular myopathy |
| F44 | M | 3 | Neurology | Genetic neurodevelopmental disorder |
| F45 | F | 15 | Neurology | Juvenile Huntington's disease |
| F46 | M | 8 | Neurology | Muscular dystrophy |